Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Rivaroxaban Day'

Rivaroxaban Day published presentations and documents on DocSlides.

Rivaroxaban compared with enoxaparin for the prevention of

Rivaroxaban compared with enoxaparin for the prevention of

  • luanne-stotts
  • 21 Slides

Alexander T Cohen . On behalf of the MAGELLAN Ste...

Update on the New Oral Anticoagulants

Update on the New Oral Anticoagulants

  • sherrill-nordquist
  • 39 Slides

Eliot Williams, MD PhD. Division of Hematology &a...

A New Era in Anticoagulation Management

A New Era in Anticoagulation Management

  • debby-jeon
  • 46 Slides

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

Novel Oral Anticoagulants

Novel Oral Anticoagulants

  • natalia-silvester
  • 88 Slides

(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...

Alexander G

Alexander G

  • min-jolicoeur
  • 35 Slides

G. . Turpie. Professor Emeritus of Medicine. McM...

Management of

Management of

  • marina-yarberry
  • 74 Slides

Atrial. Fibrillation. Phillip H. Lam, M.D.. Chie...

Recent ACS: STEMI, NSTEMI, UA

Recent ACS: STEMI, NSTEMI, UA

  • danika-pritchard
  • 20 Slides

Stabilized 1-7 Days Post-Index Event. Exclusions:...

Oral anticoagulants in the 21

Oral anticoagulants in the 21

  • natalia-silvester
  • 50 Slides

st. century: A practical guide to using newer A...

Dodson Thompson, DO

Dodson Thompson, DO

  • lois-ondreau
  • 40 Slides

Northlakes. Community Clinic. Minong, WI. Novel ...

A Multicenter Randomized Trial Evaluating Clinically Signif

A Multicenter Randomized Trial Evaluating Clinically Signif

  • ellena-manuel
  • 20 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

R eal-world

R eal-world

  • liane-varnes
  • 20 Slides

EVI. dence. on . S. troke prevention . I. n pati...

New Oral Anticoagulant

New Oral Anticoagulant

  • mitsue-stanley
  • 80 Slides

R2 Patcharee Seesongsom. R2 . Sirada. . Phoja...

Update in the Perioperative and Emergency Management of Nov

Update in the Perioperative and Emergency Management of Nov

  • danika-pritchard
  • 47 Slides

Annelise Gallien, MD FRCPC. Moncton City Hospital...

A Multicenter Randomized Trial Evaluating Clinically Signif

A Multicenter Randomized Trial Evaluating Clinically Signif

  • giovanna-bartolotta
  • 20 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

The Novel Oral Anticoagulants

The Novel Oral Anticoagulants

  • tatyana-admore
  • 47 Slides

Fawaz Altuwaijri. ACEM trainee. Introduction. Cha...

Stroke, Bleeding, and

Stroke, Bleeding, and

  • lois-ondreau
  • 7 Slides

Mortality Risks . in . Elderly Medicare Beneficia...

Rivaroxaban or Aspirin for Extended Treatment of Venous Thr

Rivaroxaban or Aspirin for Extended Treatment of Venous Thr

  • yoshiko-marsland
  • 25 Slides

(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....

Trials and Tribulations in VTE:

Trials and Tribulations in VTE:

  • celsa-spraggs
  • 0 Slides

How Do Real-World Data Fit In? . Program Goals. V...

Pharmaceutical Management of Cardiac Medications:

Pharmaceutical Management of Cardiac Medications:

  • pamella-moone
  • 0 Slides

A Look at New Oral Anticoagulants. Linda Wing, . ...

Rapid Reversal of Anticoagulation for Patients with Intracerebral Hemorrhage

Rapid Reversal of Anticoagulation for Patients with Intracerebral Hemorrhage

  • faustina-dinatale
  • 0 Slides

Fred V. Plapp MD PhD. Pathology and Laboratory Me...

Sandy Bartlett, PhD, PharmD

Sandy Bartlett, PhD, PharmD

  • mitsue-stanley
  • 0 Slides

, . BCPS, BCCCP. Associate Professor | Department...

POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF

POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF

  • phoebe-click
  • 0 Slides

NOACS IN AF. Where Do We Stand With NOACs in AF ...

A New Era in Anticoagulation Management

A New Era in Anticoagulation Management

  • alexa-scheidler
  • 0 Slides

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

New Oral Anticoagulants: A Review

New Oral Anticoagulants: A Review

  • phoebe-click
  • 0 Slides

Babak Moini, MD. Veterans Affairs Hospital. Noon ...

Pharmacology of Anticoagulants

Pharmacology of Anticoagulants

  • conchita-marotz
  • 0 Slides

Nathan Culver, . PharmD. , BCPS. anticoagulant Me...

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban

  • celsa-spraggs
  • 0 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

CAD/PAD in Primary Care CV Risk in Stable Outpatients

CAD/PAD in Primary Care CV Risk in Stable Outpatients

  • stefany-barnette
  • 0 Slides

Stratified by Baseline CV Risk Category. Aspirin ...

Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:

Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:

  • giovanna-bartolotta
  • 15 Slides

Rivaroxaban Plus Aspirin in Patients With and Wit...

Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators

Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators

  • yoshiko-marsland
  • 18 Slides

Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...

Anticoagulation and Thrombosis Management

Anticoagulation and Thrombosis Management

  • pasty-toler
  • 14 Slides

Anticoagulation and Thrombosis Management A Revie...

A ssessment of D ual antiplatelet therapy versus

A ssessment of D ual antiplatelet therapy versus

  • stefany-barnette
  • 22 Slides

A ssessment of D ual antiplatelet therapy versus...

Bleeding and cancer risk in patients with vascular

Bleeding and cancer risk in patients with vascular

  • danika-pritchard
  • 17 Slides

Bleeding and cancer risk in patients with vascul...

Ima A. Kusuma , MD, FIHA

Ima A. Kusuma , MD, FIHA

  • hirook
  • 33 Slides

“JIH. ” Hospital, Yogyakarta, Indonesia. The U...

A ssessment of D ual antiplatelet therapy versus

A ssessment of D ual antiplatelet therapy versus

  • coursion
  • 22 Slides

R. ivaroxaban . I. n atrial . F. ibrillation patie...

Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know

Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know

  • dsuser1
  • 64 Slides

Christopher Granger, . MD. Sean Pokorney, MD. . D...

Rivaroxaban in stable peripheral or carotid artery disease

Rivaroxaban in stable peripheral or carotid artery disease

  • basidell
  • 17 Slides

Sonia Anand, on . behalf of the COMPASS Steering C...

The thick and thin of it: Reviewing Anticoagulant Options

The thick and thin of it: Reviewing Anticoagulant Options

  • oneill
  • 26 Slides

Lanae Fox, . PharmD. , BCPS. I have no financial d...

Spotlight Case New Oral Anticoagulants

Spotlight Case New Oral Anticoagulants

  • skylar
  • 24 Slides

This presentation is based on the . December 2013....

New (Direct)Oral anti-coagulants in the treatment of VTE

New (Direct)Oral anti-coagulants in the treatment of VTE

  • ariel
  • 50 Slides

Dr NA Smith - Haematology Dept. Heart of England...

Management of Anticoagulant-Related Major Bleeding: Clinical Updates and Best Practices for Health-

Management of Anticoagulant-Related Major Bleeding: Clinical Updates and Best Practices for Health-

  • melanie
  • 108 Slides

Provided by ProCE, LLC and supported by an educati...

Copyright © 2024 DocSlides. All Rights Reserved